Quantcast

Latest Cancer vaccine Stories

2014-10-21 08:35:47

WORCESTER, Mass. and TORONTO, Oct.

2014-10-21 08:34:56

Management Responds To Inquiries Concerning Discovery Capabilities For Anti-Ebola Treatments SAN DIEGO, Oct. 21, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.

2014-10-15 12:32:29

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global cancer immunotherapies market reached $30.8 billion in 2012.

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct.

2014-10-14 04:22:05

TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized

2014-10-10 08:24:07

SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.

2014-10-09 08:27:10

Program Funded by the National Cancer Institute (NCI) CHARLOTTESVILLE, Va., Oct.

2014-10-02 12:28:31

LONDON, Oct. 2, 2014 /PRNewswire/ -- This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy.

2014-09-25 08:28:30

SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S.

2014-09-24 08:27:24

Ex-Vivo Manipulation of Autologous Hematopoietic Stem Cells Complements Dendritic Cell-based Vaccine Platform; Potential to Develop Single-Agent and Combination Immunotherapeutics LOS


Word of the Day
quilisma
  • In medieval musical notation, a sign or neume denoting a shake or trill.
The word 'quilisma' comes from a Greek word meaning 'a roll'.